Eli Lilly (LLY) capital expenditure was $7.8B in FY2025 (+55% YoY). The tables below show the complete quarterly and annual capital expenditure history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Capital Expenditure
Fiscal Year
Capital Expenditure
YoY
2025
$7.8B
+55%
2024
$5.1B
+47%
2023
$3.4B
+86%
2022
$1.9B
-15%
2021
$2.2B
+7%
2020
$2.0B
+61%
2019
$1.3B
-60%
2018
$3.2B
+196%
2017
$1.1B
+4%
2016
$1.0B
-3%
2015
$1.1B
-28%
2014
$1.5B
+42%
2013
$1.0B
-1%
2012
$1.0B
-20%
2011
$1.3B
+15%
2010
$1.1B
+49%
2009
$765M
-19%
2008
$947M
-12%
2007
$1.1B
Recent Quarterly Capital Expenditure
Quarter
Capital Expenditure
Q1 2026
$2.3B
Q4 2025
$2.5B
Q3 2025
$2.1B
Q2 2025
$1.7B
Q1 2025
$1.5B
Q4 2024
$1.5B
Q3 2024
$1.4B
Q2 2024
$1.2B
Q1 2024
$986M
Q4 2023
$1.1B
Q3 2023
$970M
Q2 2023
$738M
Source: LLY on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.